Community-based prostate cancer screening in Japan: Predicting factors for positive repeat biopsy

International Journal of Urology

Volumn 17, Issue 6, 2010, Pages 541-547

  Okada, Koichi ^a   Okihara, Koji ^b   Kitamura, Koji ^c   Mikami, Kazuya ^b   Ukimura, Osamu ^b   Kawauchi, Akihiro ^b   Kamoi, Kazumi ^b   Nakao, Masahiro ^a   Miki, Tsuneharu ^b  

^a MEIJI UNIVERSITY OF INTEGRATIVE MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c Department of Urology Saiseikai Kyoto Hospital ^*  (Japan)

Author keywords

Prostate cancer screening; Prostate specific antigen density; Prostate specific antigen velocity; Repeat biopsy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER GRADING; CANCER SCREENING; COMMUNITY; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; HIGH RISK PATIENT; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; AGED; BIOPSY; FORECASTING; MASS SCREENING; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR; STATISTICS AND NUMERICAL DATA;

AGED; BIOPSY; FORECASTING; HUMANS; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS;

EID: 77952739229     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02517.x     Document Type: Article

References (19)

1. Japanese Urological Association (ed.). Japanese Urological Association Guidelines on Prostate-Specific Antigen-Based Screening for Prostate Cancer. Kanehara
2. Benson MC, Whang IS, Pantuck A et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J. Urol. 1992 147: 815 816.
3. Etzioni RD, Ankerst DP, Weiss NS, Inoue LY, Thompson IM. Is Prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence. J. Natl. Cancer Inst. 2007 180: 1510 1515.
4. Okihara K, Kitamura K, Okada K, Mikami K, Ukimura O, Miki T. Ten year trend in prostate cancer screening with high prostate-specific antigen exposure rate in Japan. Int. J. Urol. 2008 15: 156 160.
5. Ito K, Kakehi Y, Naito S, Okuyama A, Japanese Urological Association. Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan. Int. J. Urol. 2008 15: 763 768.
6. Akakura K. Screening of Prostate Cancer A to Z. Ichikawa T, Suzuki K (eds) Medical View
7. Keetch DW, McMurtry JM, Smith DS, Andriole GL, Catalona WJ. Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies. J. Urol. 1996 156 (2 Pt 1 428 431.
8. Morgan TO, McLeod DG, Leifer ES, Moul JW, Murphy GP. Prospective use of free PSA to avoid repeat prostate biopsies in men with elevated total PSA. Prostate Suppl. 1996 7: 58 63.
9. Djavan B, Zlotta A, Remzi M et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J. Urol. 2000 163: 1144 1148.
10. Borboroglu PG, Sur RL, Roberts JL, Amling CL. Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J. Urol. 2001 166: 866 870.
11. Lopez-Corona E, Ohori M, Scardino PT, Reuter VE, Gonen M, Kattan MW. A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. J. Urol. 2003 170 (4 Pt 1 1184 1188.
12. Zackrisson B, Aus G, Lilja H, Lodding P, Pihl CG, Hugosson J. Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. Eur. Urol. 2003 43: 327 332.
13. Park SJ, Miyake H, Hara I, Eto H. Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy. Int. J. Urol. 2003 10: 68 71. (Pubitemid 36398912) (Pubitemid 36398912)
14. Singh H, Canto EI, Shariat SF et al. Predictors of prostate cancer after initial negative systematic 12 core biopsy. J. Urol. 2004 171: 1850 1854.
15. Garzotto M, Park Y, Mongoue-Tchokote S et al. Recursive partitioning for risk stratification in men undergoing repeat prostate biopsies. Cancer 2005 104: 1911 1917.
16. Yanke BV, Gonen M, Scardino PT, Kattan MW. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. J. Urol. 2005 173: 421 424.
17. Walz J, Graefen M, Chun FK et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur. Urol. 2006 50: 498 505.
18. Chun FK, Briganti A, Graefen M et al. Development and external validation of an extended repeat biopsy nomogram. J. Urol. 2007 177: 510 515. (Pubitemid 46054043) (Pubitemid 46054043)
19. Yuasa T, Tsuchiya N, Kumazawa T et al. Characterization of prostate cancer detected at repeat biopsy. BMC Urol. 2008 8: 14.